Key Record Dates
ClinicalTrials.gov Identifier: | NCT04079738 |
---|---|
Brief Title: | Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib |
First Submitted : | September 3, 2019 |
First Submitted that Met QC Criteria : | September 4, 2019 |
First Posted : | September 6, 2019 |
Last Update Submitted that Met QC Criteria : | March 15, 2022 |
Last Update Posted : | March 31, 2022 |